For cardiovascular risk reduction, it is only approved for adults 18 years and older with type 2 diabetes
Proceedings of the National Academy of Sciences of the United States of America, doi: 10.1073/pnas.1423857112 (2015)
When to Contact Your PlexusDx Provider About Dosing Concerns If you're experiencing severe nausea, vomiting, or other side effects that make you consider splitting doses, reach out to your PlexusDx clinical team before making any changes
Stopping semaglutide abruptly is not recommended, and tapering under medical supervision helps manage risks
Nat Rev Drug Discovery (2022) 21:20123
We specialize in GLP-1 weight loss therapy and peptide wellness, offering focused expertise that general primary care platforms don't match